AstraZeneca announces new deals with biotechs

02/1/2007 | Bloomberg · Reuters

AstraZeneca said it will acquire U.K. biotech company Arrow Therapeutics for $150 million to boost research on bacteria and virus compounds, a day after announcing two licensing agreements worth $800 million to develop obesity and respiratory drugs. The drugmaker also announced plans to cut 3,000 jobs.

View Full Article in:

Bloomberg · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA